Search Results - "Rinscheid, Andreas"
-
1
Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery
Published in Physics in medicine & biology (21-05-2019)“…In proton therapy, patients benefit from the precise deposition of the dose in the tumor volume due to the interaction of charged particles with matter…”
Get more information
Journal Article -
2
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Published in EJNMMI physics (17-06-2020)“…Background Individualized dosimetry is recommended for [ 177 Lu]Lu-PSMA radioligand therapy (RLT) which is resource-intensive and protocols are often not…”
Get full text
Journal Article -
3
Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
Published in EJNMMI research (26-04-2024)“…Background In patients with prostate cancer (PCa), imaging with gastrin-releasing peptide receptor (GRPR) ligands is an alternative to PSMA-targeted tracers,…”
Get full text
Journal Article -
4
PROLONGED AND INTENSE UPTAKE OF [177LU]LU-FAP-RTX IN MYOEPITHELIAL CARCINOMA: A CASE REPORT
Published in Hematology, Transfusion and Cell Therapy (01-04-2024)“…Introduction/Justification: We present a case of a 71-year-old male patient diagnosed with myoepithelial carcinoma of the pelvis and perineum, who underwent…”
Get full text
Journal Article -
5
Convolutional neural networks for automatic image quality control and EARL compliance of PET images
Published in EJNMMI physics (09-08-2022)“…Background Machine learning studies require a large number of images often obtained on different PET scanners. When merging these images, the use of harmonized…”
Get full text
Journal Article -
6
Prompt gamma spectroscopy for range control with CeBr3
Published in Current directions in biomedical engineering (01-09-2017)“…The ultimate goal of radiotherapy using external beams is to maximize the dose delivered to the tumor while minimizing the radiation given to surrounding…”
Get full text
Journal Article -
7
An Intrapatient Dosimetry Comparison of 177Lu-rhPSMA-10.1 and 177Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Published in The Journal of nuclear medicine (1978) (01-12-2023)“…As the use of radioligand therapy moves earlier in the prostate cancer timeline, minimizing the absorbed dose to normal organs while maintaining high tumor…”
Get full text
Journal Article -
8
[99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
Published in European journal of nuclear medicine and molecular imaging (01-11-2023)“…Purpose The clinical success non-invasive imaging of CXCR4 expression using [ 68 Ga]Ga-PentixaFor-PET warrants an expansion of the targeting concept towards…”
Get full text
Journal Article -
9
An Intrapatient Dosimetry Comparison of 177 Lu-rhPSMA-10.1 and 177 Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Published in Journal of Nuclear Medicine (01-12-2023)“…As the use of radioligand therapy moves earlier in the prostate cancer timeline, minimizing the absorbed dose to normal organs while maintaining high tumor…”
Get full text
Journal Article -
10
Optimal sampling schedule for dosimetry: A simulation study
Published in The Journal of nuclear medicine (1978) (01-05-2018)“…Objectives: For dosimetry in nuclear medicine, the areas under the organ time-activity curves have to be determined. To reduce resources, the biokinetics and…”
Get full text
Journal Article -
11
Modeling and Predicting Tumor Response in Radioligand Therapy
Published in Journal of Nuclear Medicine (01-01-2019)“…The aim of this work was to develop a theranostic method that allows prediction of prostate-specific membrane antigen (PSMA)-positive tumor volume after…”
Get full text
Journal Article -
12
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
Published in Journal of Nuclear Medicine (24-10-2024)“…Peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with advanced meningioma. Recently, intraarterial application of the…”
Get full text
Journal Article -
13
First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
Published in The Journal of nuclear medicine (1978) (01-03-2024)“…We recently published the first dosimetry data, to our knowledge, for the radioligand therapy agent 177Lu-rhPSMA-10.1, providing an intrapatient comparison…”
Get full text
Journal Article -
14
Experience of rescue therapy with 177LuLu-rhPSMA-10.1 in patients with primary or acquired resistance to 177LuLu-PSMA-I&T
Published in European journal of nuclear medicine and molecular imaging (04-11-2024)“…Radioligand therapy is an increasingly important option for the treatment of metastatic castrate-resistant prostate cancer (mCRPC). Radiohybrid ligands…”
Get full text
Journal Article -
15
First Safety and Efficacy Data with the Radiohybrid 177 Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
Published in Journal of Nuclear Medicine (01-03-2024)“…We recently published the first dosimetry data, to our knowledge, for the radioligand therapy agent Lu-rhPSMA-10.1, providing an intrapatient comparison with…”
Get full text
Journal Article -
16
Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T
Published in European journal of nuclear medicine and molecular imaging (04-11-2024)“…Abstract Purpose Radioligand therapy is an increasingly important option for the treatment of metastatic castrate-resistant prostate cancer (mCRPC)…”
Get full text
Journal Article -
17
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177 Lu-PSMA therapy
Published in Medical physics (Lancaster) (01-12-2019)“…Accurate and precise renal dosimetry during Lu-labeled prostate-specific membrane antigen (PSMA) radioligand therapy is crucial for therapy decisions. Sampling…”
Get full text
Journal Article -
18
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu‐PSMA therapy
Published in Medical physics (Lancaster) (01-12-2019)“…Purpose Accurate and precise renal dosimetry during 177Lu‐labeled prostate‐specific membrane antigen (PSMA) radioligand therapy is crucial for therapy…”
Get full text
Journal Article -
19
Optimal sampling schedules for kidney dosimetry for 177Lu-PSMA therapy
Published in The Journal of nuclear medicine (1978) (01-05-2019)“…Objectives: The decision on additional therapy cycles for patients undergoing radioligand therapy is often based on kidney dosimetry. Thus, the time-integrated…”
Get full text
Journal Article -
20
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [ 99m Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Published in Journal of Nuclear Medicine (01-10-2024)“…C-X-C motif chemokine receptor 4 (CXCR4)-directed imaging has gained clinical interest in aiding clinical diagnostics in primary aldosteronism (PA). We…”
Get full text
Journal Article